Press Releases Chimeric Therapeutics Announces FDA Clearance of IND Application for CHM 2101, A Novel CDH17 CAR T Cell Therapy for Advanced Gastrointestinal Cancers Read More » October 2023
Press Releases Positive Preliminary Phase 1A Data For CLTX CAR T in Recurrent Brain Cancer Clinical Trial Read More » October 2023